SDI Group plc
("SDI", the "Company", or the "Group")
AGM Trading Update
26 September 2024 - SDI Group plc, the AIM quoted Group focused on the design and manufacture of products for use in the lab equipment, industrial & scientific sensors and the industrial & scientific products markets, provides an update on trading for the current financial year ("FY25") ahead of today's Annual General Meeting ("AGM").
The Company expects to deliver full year results in line with market expectations1. Profit and revenue delivery in FY25 will be weighted more towards H2 than in FY24 due to the current financial year starting slowly, reflecting conditions in certain customer markets. Cash flow has continued to be strong, with unaudited net debt reducing to £11.3m at the end of August 2024 (30 April 2024: £13.2m).
SDI remains focused on deploying its dual pronged growth strategy, namely supporting organic growth through initiatives within the portfolio businesses, alongside value-enhancing acquisitions to drive inorganic growth.
1Analysts from our Broker Cavendish Capital Markets Limited and from Progressive Equity Research regularly provide research on the Company, accessible from our website, and the Group considers the average of their forecasts to represent market expectations for FY25 being Sales of £69.0m and Adjusted Profit Before Tax of £8.35m.
| Enquiries:
| ||
|
| SDI Group plc Stephen Brown, Chief Executive Officer Amitabh Sharma, Chief Financial Officer | +44 (0)1223 727144 |
|
|
Cavendish Capital Markets Ltd (NOMAD & broker) Ed Frisby / Seamus Fricker - Corporate Finance Andrew Burdis / Sunila de Silva - ECM
|
+44 (0)20 7220 0500 |
|
| Vigo Consulting (Financial Communications) Tim McCall / Rozi Morris / Fiona Hetherington
| +44 (0)20 7390 0230 |
About SDI Group plc:
SDl Group plc, specialises in the acquisition and development of companies that design and manufacture products for use in the lab equipment, industrial & scientific sensors and the industrial & scientific products markets. SDI's current portfolio of 14 companies target markets including life sciences, healthcare, astronomy, plastics and packaging, manufacturing, precision optics, measurement instrumentation and art conservation.
SDI's growth strategy is twofold: 1) through the enhancement of its portfolio companies (organic growth) and, 2) through the identification and acquisition of complementary, niche technology businesses with established reputations in global markets (inorganic growth).
For more information, please see: www.SDIGroup.com
The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
